Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
PTC Therapeutics (PTCT)
NASDAQ:PTCT
PTC Therapeutics (PTCT) Stock Forecast & Price Target
310 Followers
See the Price Targets and Ratings of:
PTCT Analyst Ratings
Hold
5 Buy
6 Hold
3 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PTCT Stock 12 Month Forecast
Average Price Target
$39.80
▲(21.97% Upside)
| Highest Price Target$62.00 | Average Price Target$39.80 | Lowest Price Target$25.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
Morgan Stanley
Reiterated
07/12/24
Cantor Fitzgerald
Reiterated
07/01/24
Leerink Partners
Reiterated
06/28/24
Goldman Sachs
Reiterated
06/28/24
Bank of America Securities
Reiterated
06/28/24
William Blair
Reiterated
06/28/24
Jefferies
Reiterated
06/28/24
Wells Fargo
Reiterated
06/28/24
J.P. Morgan
Reiterated
06/20/24
Citi
Reiterated
06/20/24
RBC Capital
$29→$39
Hold
$39.00
(19.52% Upside)
Reiterated
05/20/24
RBC Capital Sticks to Its Hold Rating for PTC Therapeutics (PTCT)
Raymond James
―
Hold
―
Upgraded
05/20/24
PTC Therapeutics upgraded to Market Perform from Underperform at Raymond JamesPTC Therapeutics upgraded to Market Perform from Underperform at Raymond James
Barclays
$25
Hold
$25.00
(-23.38% Downside)
Reiterated
04/26/24
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (NASDAQ: BMRN), PTC Therapeutics (NASDAQ: PTCT) and Teladoc (NYSE: TDOC)
Truist Financial
$25
Hold
$25.00
(-23.38% Downside)
Reiterated
11/21/23
Truist Financial Keeps Their Hold Rating on PTC Therapeutics (PTCT)
Best Analysts Covering PTC Therapeutics
Which Analyst Should I Follow If I Want to Buy PTCT and Sell After:
1 Month
xxx
Success Rate
9/13 ratings generated profit
Average Return
+2.74%
reiterated a xxx
rating 24 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 69.23% of your transactions generating a profit, with an average return of +2.74% per trade.
3 Months
xxx
Success Rate
8/13 ratings generated profit
Average Return
+11.63%
reiterated a xxx
rating 24 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 61.54% of your transactions generating a profit, with an average return of +11.63% per trade.
1 Year
2 Years
xxx
Success Rate
10/16 ratings generated profit
Average Return
-9.74%
reiterated a xxx
rating 24 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 62.50% of your transactions generating a profit, with an average return of -9.74% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PTCT Analyst Recommendation Trends
Rating
Mar 24
Apr 24
May 24
Jun 24
Jul 24
Strong Buy
1
0
0
3
4
Buy
8
8
11
12
9
Hold
9
12
14
13
8
Sell
5
4
8
11
9
Strong Sell
0
0
0
0
0
total
23
24
33
39
30
Each month's total comprises the sum of three months' worth of ratings.
PTCT Financial Forecast
PTCT Stock Forecast FAQ
What is PTCT’s average 12-month price target, according to analysts?
Based on analyst ratings, PTC Therapeutics’s 12-month average price target is $39.80.
What is PTCT’s upside potential, based on the analysts’ average price target?
PTC Therapeutics has 21.97% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PTCT a Buy, Sell or Hold?
PTC Therapeutics has a consensus rating of Hold which is based on 5 buy ratings, 6 hold ratings and 3 sell ratings.
What is PTC Therapeutics’s price target?
The average price target for PTC Therapeutics is $39.80. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $62.00 ,the lowest forecast is $25.00. The average price target represents 21.97% Increase from the current price of $32.63.
The highest analyst price target is $62.00 ,the lowest forecast is $25.00. The average price target represents 21.97% Increase from the current price of $32.63.
What do analysts say about PTC Therapeutics?
PTC Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of PTCT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.